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Changing Ethnic Disparity in Ischemic StrokeMortality
in US Children After the STOP Trial
Laura L. Lehman, MD; Heather J. Fullerton, MD, MAS
IMPORTANCE A prior report showed higher strokemortality in US black children compared
with white children (1979-1998), a disparity likely due in part to sickle cell disease, which
leads to a high risk of childhood ischemic stroke. We hypothesized that this disparity has
diminished since the publication of the Stroke Prevention Trial in Sickle Cell Anemia (STOP
trial) in 1998 demonstrating the efficacy of long-term blood transfusions for primary stroke
prevention.
OBJECTIVE To evaluate the demographics and secular trends in mortality from ischemic and
hemorrhagic stroke (as a primary cause of death) in US children (<20 years) and determine if
there has been a decrease in the disparity between white and black children since the
publication of the STOP trial in 1998.
DESIGN We used death certificate data from the National Center for Health Statistics, 1988
through 2007.
SETTING United States.
PARTICIPANTS Children who died in 1988 through 2007 in the United States.
INTERVENTION Publication of the STOP trial.
MAIN OUTCOMEMEASURES Incidence rate ratios were calculated as themeasure of relative
risk.
RESULTS Among 1.6 billion person-years of US children (1988-2007), there were 4425 deaths
attributed to stroke, yielding an average of 221 deaths per year; 20%were ischemic; 67%,
hemorrhagic; and 12%, unspecified. The relative risk of ischemic strokemortality for black vs
white children dropped from 1.74 from 1988 through 1997 to 1.27 from 1998 through 2007.
The ethnic disparity in hemorrhagic strokemortality, however, remained relatively stable
between these 2 periods: black vs white relative risk, 1.90 (1988-1997) and 1.97 (1998-2007).
CONCLUSIONS AND RELEVANCE The excess risk of death from ischemic, but not hemorrhagic,
stroke in US black children has decreased over the past decade. This may be related to the
implementation of an effective ischemic stroke prevention strategy for children with sickle
cell disease.
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S troke is one of the top 10 leading causes of childhooddeath in the United States.1 A decline in pediatric strokemortalitywas observed in a recent study inEngland and
Wales that examined birth cohorts from 1921 to 2000. Higher
mortality rates in males, compared with females, and infants,
compared with older children, were observed; however, the
study did not address ethnicity as a risk factor.2 Older epide-
miological studies intheUnitedStateshavesuggestedthatblack
childrenhaveanincreasedriskofbothincidentstrokeandstroke
mortality. In a studyof childhood stroke admissions inCalifor-
nia from1991 to2000,blackchildren,comparedwithwhitechil-
dren, had amore than 2-fold increased risk of ischemic stroke
and 60% increased risk of hemorrhagic stroke.3 A study of all
deaths in theUnitedStates from1979 to 1998 similarlydemon-
strated that black children, again compared with white chil-
dren, have a higher mortality from ischemic and hemorrhagic
stroke.4 California newborn screening found that 88%of new-
borns who tested positive for sickle cell disease were black vs
12% who were nonblack.5 Sickle cell disease, which predomi-
nantlyaffectsblackchildren, likelyplaysa role in theethnicdis-
parity in childhood stroke risk. It is a powerful risk factor for
childhoodischemicstroke:oldnaturalhistorystudiesfoundthat
approximately 10% of children with sickle cell disease had an
ischemic stroke by the age of 20 years.6,7
However, thedemographics of childhood strokemayhave
changed in the past decade with the publication of the Stroke
PreventionTrial inSickleCellAnemia (STOPTrial) in 1998.8The
STOPtrialdemonstratedthat,amongchildren identifiedashigh
risk for stroke through screeningwith transcranial Doppler ul-
trasonography, long-term blood transfusion therapy de-
creases the risk of stroke by more than 90%. Since 1998, a de-
cline in first-time stroke incidence rates in childrenwith sickle
cell disease has been suggested bymultiple studies and attrib-
utedto increasedtranscranialDopplerultrasonographyscreen-
ing and blood transfusion therapy.9-12 The impact of the STOP
trial on pediatric strokemortality rates has not been assessed.
We hypothesized that the ethnic disparity in childhood
stroke mortality has diminished since the publication of the
STOP trial in 1998. Because childhood strokes in the setting of
sicklecelldiseaseare ischemic75%to95%ofthetime,wewould
expect the STOP trial to have a greater impact on ethnic dis-
parities in ischemic thanhemorrhagic stroke.6,7,9,13 To test this
hypothesis,weevaluated thedemographicsandsecular trends
inmortality from ischemic and hemorrhagic stroke in US chil-
drenyounger than20yearsusingdeathcertificatedata fromthe
NationalCenter forHealthStatistics (NCHS) from1988 to2007.
Methods
Our study cohort included all US children from 1988, 1 decade
prior to thepublicationof theSTOPtrial, through2007, themost
recentyear forwhichNCHSmortalitydatawereavailable at the
time of the study. Because theNCHSdatabase groups 15- to 19-
year-olds together, we defined childhood as younger than 20
years.Within this cohort,we identifiedchildhoodstrokedeaths
by searching themortality database of theNCHSusing Interna-
tionalClassificationofDiseases,NinthRevision (ICD-9) (eTable 1
in Supplement) and ICD-10 (eTable 2 in Supplement) codes for
ischemic and hemorrhagic stroke.14 The database used ICD-9
codes from 1988 to 1998 and ICD-10 codes from 1999 to 2007.
Weusedstroke ICD-9codespublished inapriorarticleonchild-
hoodstrokedeathsintheUnitedStatesandtheequivalent ICD-10
codes.4,15Hemorrhagic stroke includedboth subarachnoidand
intracerebral hemorrhagewhile ischemic stroke included both
venous sinus thrombosis and arterial ischemic stroke.
WeusedNCHSmethods for determiningmortality rates.16
Ingeneral, theNCHScalculatescrudeannualizedmortalityrates
as the number of deaths reported each calendar year divided
by theestimatednumberof people in thepopulation; the rates
are expressedasdeathsper 100 000person-years.Whena rate
is calculated formultipleyears, the totalnumberofdeathsdur-
ing that epoch is divided by the sum of the population esti-
mates for each individual year. From 1980 to 1998, the NCHS
calculatedannualizedmortality rates for infants (<1year) as the
number of infant deaths (children <1 year at the time of death)
dividedbythenumberof livebirthsduringagivenperiod; from
1999 through2007, theycalculatedmortality rates as thenum-
ber of infant deaths divided by the estimated number of in-
fants in the population.17When theNCHS comparedmortality
rates using live births compared with population estimation,
there was only a slight difference in rates.16 The NCHS data-
base classified race into 3 mutually exclusive categories from
1988to1998,whichincludedblack,white,andother,while from
1999 to 2007, the NCHS database classified race into 4 mutu-
ally exclusive groups, black, white, American Indian or Alaska
native, and Asian or Pacific islander.18 For our analysis, which
is a comparison of black andwhite children, we combined the
latter 2 groups into the "other" category.
Our primary analysis included all children younger than
20 years for consistencywith the previously published report
on US childhood stroke mortality.4 Since the recommenda-
tions fromtheSTOP trial donot apply to childrenyounger than
2 years, we performed a secondary analysis excluding infants
(<1 year). The NCHS mortality database used in our analyses
categorizes age as follows: younger than 1 year, 1 to 4 years, 5
to 9 years, 10 to 14 years, and 15 to 19 years. Hence, we could
not isolate 1- and 2-year-olds.
For our analyses of temporal trends in strokemortality,we
used the direct method of standardization to age adjust mor-
tality rates to the 1990USpopulation tobe consistentwithpre-
vious publication.4 For graphical purposes only, themortality
rateswere smoothedusing a 3-pointmoving average andaver-
aging end points with nearest neighbors. To compare mortal-
ity rates,wecalculated incidencerateratiosasameasureof rela-
tive risk. Because our study cohort included the entire
population ofUS children, rather than a sample of this popula-
tion, confidence intervalsmay be superfluous but were calcu-
latedoutof convention.All statistical analysesweredoneusing
Stata (version 11; StataCorp).
Results
Our study cohort included a total of 1 555 045 537 person-
years of US children. Black children accounted for 16% of the
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populationandsexwasdistributedevenly (Table 1).Within this
cohort, childhood stroke was named as the primary cause of
death in4425 children in theUnited States from1988 through
2007, averaging 221 strokedeathsper year. Ischemic stroke ac-
counted for 20%ofdeaths; hemorrhagic strokes accounted for
67%;and12%wereunspecified.Averageannualmortality rates
were0.285per 100 000person-years forall stroke types;0.058,
for ischemic stroke; and 0.181, for hemorrhagic stroke.
While the ethnic disparity in hemorrhagic stroke mortal-
ity has remained relatively stable over the study period, is-
chemic stroke mortality rates in black vs white children ap-
pear to be converging (Figure 1). The excess risk of ischemic
stroke mortality in black vs white children decreased by al-
most two-thirds, from74%(1988-1997) to27%(1998-2007); the
excess risk of hemorrhagic stroke mortality remained un-
changed (Table 2). In our secondary analysis in which we ex-
cluded children younger than 1 year, the relative risk of ische-
mic strokemortality for black vswhite childrenwas 1.72 (95%
CI, 1.27-2.29) from 1988 through 1997 and 1.09 (95% CI, 0.75-
1.54) from 1998 through 2007. The relative risk of hemor-
rhagicstrokemortality forblackvswhitechildrenwas1.39 (95%
CI, 1.18-1.63) from 1988 through 1997 and 1.67 (95% CI, 1.42-
1.96) from 1998 through 2007. To determine whether the de-
cline in ischemic strokemortality in black childrendifferedby
age group, we calculated the average annual mortality rates
before and after 1998, stratified by age; all age groups showed
a decline, even the younger than 1 year group, who had a pre-
1998strokemortality rateof0.93per 100 000person-yearsand
post-1998 rate of 0.55 per 100 000 person-years. We com-
pared the age groups that should be affected by the STOP trial
and found the greatest change in older adolescents (Figure 2).
Discussion
The excess risk of death from ischemic, but not hemorrhagic,
stroke in US black children has decreased over the past de-
cade. The only major change in childhood stroke care during
this period was the initiation of long-term blood transfusion
therapy forprimarystrokeprevention insicklecelldisease.The
STOP trial randomized children with sickle cell disease, aged
2 to 18 years, identified as high risk for stroke based on trans-
cranial Doppler ultrasonography, to long-termblood transfu-
siontherapyorstandardcare.Thetrialdemonstratedthat treat-
Table 1. Study Population of All US Children, 1988 Through 2007
Characteristic Person-years %
Race
Black 248 547 617 16
White 1 224 001 441 79
Other 82 496 479 5
Sex
F 758 405 904 49
M 796 639 633 51
Age, y
<1 80 094 608 5
1-4 311 128 987 20
5-9 387 876 812 25
10-14 389 043 279 25
15-19 386 901 851 25
Figure 1. Time Trends in US Childhood StrokeMortality Rates From 1988
Through 2007 in Black Children vsWhite Children
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Figure 2. Ischemic StrokeMortality Rates in US Black Children From 1988
Through 1997 ComparedWith 1998 Through 2007, Stratified by Age
at the Time of Death
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Table 2. Ischemic and Hemorrhagic StrokeMortality in US Black
vsWhite Children, 0 to 19 Years of Age, 1988 Through 1997 and 1998
Through 2007
Stroke Type
Stroke Mortality per 100 000
Black White Relative Risk (95% CI)
1988-1997
Ischemic 0.106 0.061 1.74 (1.42-2.13)
Hemorrhagic 0.317 0.167 1.90 (1.68-2.14)
1998-2007
Ischemic 0.058 0.045 1.27 (0.99-1.64)
Hemorrhagic 0.332 0.168 1.97 (1.76-2.20)
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ing high-risk childrenwith transfusion therapydecreased the
risk of stroke bymore than 90%.8 The impact of the interven-
tion occurred quickly: the stroke-free survival curves of the
transfusion group vs the standard-care group diverged after
6 months.8 A Clinical Alert by the National Heart, Lung, and
Blood Institutemade the STOP trial results public in 1997 and
the results were published in 1998.19
To determine whether the observed decline in stroke
deaths inUSblackchildrencouldbeattributedto theSTOPtrial,
we used published rates of the prevalence of sickle cell dis-
ease, the incidence of stroke in children with sickle cell dis-
ease, and the case fatality of childhood stroke to estimate the
absolutenumberof strokedeaths that theSTOPtrial couldpre-
vent per year. There are approximately 12.8millionblack chil-
dren younger than 20 years in the United States. Newborn
screening results in California found that 1 in 396 black chil-
dren have sickle cell disease; hence, there are approximately
32 300 black children younger than 20 years with sickle cell
disease.20 Prior to the STOP trial, the rate of stroke in children
with sickle cell disease was 285 per 100 000 person-years;
hence, there would be approximately 92 sickle cell disease–
related ischemic strokes per year.21 If the STOP trial recom-
mendations have been completely implemented, incident
strokes should be reduced by 90%, meaning that 83 strokes
would be prevented per year. Based on a 4% case fatality rate
for childhood stroke, the STOP trial should prevent 3 stroke
deaths per year.22 The absolute number of ischemic stroke
deaths amongUS black childrenwas 11 in 1990, and 8 in 2007,
corresponding with the estimated impact of the STOP trial.
In our study, the ethnic disparity in ischemic stroke mor-
tality inUSchildrenbegan todiminishevenprior to 1998,when
theSTOP trial resultswerepublished. It is possible that clinical
practice changedwhile the STOP trial was under way. In 1992,
apublicationby theSTOPtrial investigatorsdemonstrated that
screeningwithtranscranialDopplerultrasonographycouldiden-
tify those children at extremely high risk of first stroke; at that
time,blood transfusion therapywasalready thestandard treat-
ment for secondary strokeprevention.23Thehematologycom-
munitywashighlyawareof the trial; it ispossible that somebe-
gan screening and treating patients even before the STOP trial
resultswereformallyannounced.However,other literaturesug-
gests that transcranial Doppler ultrasonography screening in-
creased after the publication of the STOP trial, from 1.8 per
100 000person-yearspre-1998 inCalifornia, to5.0per 100 000
person-years from1998through1999,and11.4per 100 000per-
son-years after 1999.12 A decrease in stroke admissions in chil-
dren with sickle cell disease was also seen in California start-
ing in 1999.9 Therefore, application of the STOP trial
recommendations likely played a role in the narrowing ethnic
disparity in ischemic stroke mortality in US children over the
past decade.
Wehypothesized thatwewould observe a greater change
in ethnic disparities in ischemic stroke than hemorrhagic
stroke. Although the STOP trial included both ischemic and
hemorrhagic strokesasoutcomes, 11 of the 12observedstrokes
were ischemic, the most common stroke type among chil-
dren with sickle cell disease.6-9,13 Hence, the anticipated im-
pact of the trial was primarily on childhood ischemic stroke,
andwe indeed founddeclining ethnic disparities inmortality
from ischemic, but not hemorrhagic, stroke.
Our observation of declining ischemic stroke mortality
amongblackchildrencrossed the full age range included in the
STOP trial. Prior to 1998, the highest ischemic stroke mortal-
ity rate in theUSpediatricblackpopulationwas inchildrenaged
15 to 19years.This groupalsohad the largestdecrease in stroke
mortality after 1998.These results correlatewith anatural his-
tory study thatdemonstrated that themajorityofpediatricpa-
tients with sickle cell disease who died of stroke were be-
tween 10 and 19 years of age.24
Several retrospective studieshavedemonstrated adecline
in the incidence of first-time stroke in childrenwith sickle cell
disease since 1998.9-12 Furthermore, a recentprospective study
demonstrated that the implementationof theSTOPprotocol in
a sickle cell populationdecreases thecumulative riskof stroke.
The study examined a cohort of patients in France with sickle
cell diseasewhowere diagnosed by newborn screen, followed
with transcranial Doppler ultrasonography screening, and
treatedwith long-term transfusion according to the STOPpro-
tocol. Theywere found tohaveacumulative stroke riskof 1.9%
by the age of 18 years, a notable difference from the historical
natural history data: 10% cumulative risk of stroke by the age
of 20 years.6,25 These results demonstrate that stroke risk can
be decreased in a population as well as in the setting of a trial.
If the STOP trial hasmade an impact on the incidence of stroke
in children with sickle cell disease, it follows that it would im-
pactstrokemortality,explainingourobservednarrowing ineth-
nic disparity in ischemic strokemortality.
However, several findings suggest that the STOP trialmay
not have been the only change to impact the ethnic dispari-
ties in childhood ischemic strokemortality.Asmentionedear-
lier, the disparity began to decline even prior to the publica-
tionof theSTOPtrial in 1998. Inaddition,weobservedadecline
in the ethnic disparity in stroke mortality in infants, an age
groupthat shouldnotbe impactedby theSTOPtrial.Otherdata
suggest that sickle cell disease may not be the sole explana-
tion for ethnic disparities in childhood stroke. A California
study examining childhood stroke admissions from 1991
through2000 found that, comparedwithwhite children,black
childrenwere at 2.6-fold increased risk of ischemic stroke and
1.6-fold increasedriskofhemorrhagicstroke.Amongblackchil-
dren admitted with ischemic stroke, 38% had a diagnosis of
sickle cell disease;whencaseswith sickle cell diseasewere ex-
cluded, black children still had a 61% increased risk of stroke
comparedwithwhite children.3Adult studieshave shownthat
black individuals have a higher incidence of, and mortality
from, both hemorrhagic and ischemic stroke compared with
white individuals.26-29 These disparities have largely been at-
tributedtohigher ratesandpoorercontrolofhypertension,dia-
betes, andsmoking,whichareuncommonrisk factors forchild-
hood stroke.30,31 Other genetic or environmental factors may
contribute to theethnicdisparities instroke incidenceandmor-
tality in both black adults and children. However, sickle cell
disease likely played amajor role in the ethnic disparity for is-
chemic stroke in the young, and we are not aware of other
changes in clinical care that could explain the declining dis-
parity in stroke mortality.
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Our study had several limitations. Because theNCHSmor-
tality database does not provide information on secondary di-
agnoses, likesicklecelldisease,wecouldnotdeterminewhether
strokedeathswithin thisparticular subgroupchanged.Wewere
unable to determine whether the changes in stroke mortality
were due to a decrease in case fatality or a decrease in the inci-
dence of childhood stroke. Furthermore, as in any administra-
tivestudyusing ICD-9and ICD-10codes, there isalways thepos-
sibilityofcodingerror.Deathcertificatediagnosisofadultstroke
using ICD-8 and ICD-9 codeshas been shown tohavebothhigh
specificity and high predictive value, and a recent comparabil-
ity study demonstrated that ICD-9 and ICD-10 codes for adult
cerebrovascularmortalityweresimilar,withacomparability ra-
tioof1.0588.15,32However,theNCHSmortalitydatabaseswitched
from ICD-9 to ICD-10 codes in 1999, the year after the publica-
tion of the STOP trial,which raises the possibility that our find-
ingswererelatedtoachangeincoding. Itseemsunlikely, though,
that such change would be different for black children com-
paredwithwhite children.Despite these limitations, this study
provides indirectevidence thatNational InstitutesofHealth in-
vestment insicklecelldiseasestroke researchhasnarrowedthe
ethnic gap in childhood ischemic strokemortality.
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